In contrast to glutamine, the increased intercellular concentration of L-Arginine directly enhances remarkable metabolic reprogramming and survival capacity of CD4+ and CD8+ T cells, independently of mTOR signaling or downstream metabolites, thus, improves anti-tumor activity (119). This evidence concerns the gene CD8A and neoplasm.